Mettler’s QMS Certifies as Compliant with the ISO 9001:2000
News Nov 24, 2005
Mettler Toledo has announced that their Real Time Analytics product group’s Quality Management System (QMS) has been certified as compliant with the International Standard ISO 9001:2000.
This achievement was a direct result of the entire organization working together in effectively developing and maintaining the Quality Management System.
In recognizing the ever-growing customer demand for the highest level of quality, the Mettler Toledo Real Time Analytics product group demonstrated commitment to continuous improvement of their management system by achieving this certification.
"I would like to congratulate our group for reaching the next milestone in our travels to 'Better Quality'," commented Roel Ferwerda, General Manager, Mettler Toledo Real Time Analytics.
"This is not the end; this is the beginning! ISO 9001:2000 certification stands for more than a higher quality product."
"It represents a commitment by management and personnel to establish best business practices that effectively align with our company goals and objectives, and most importantly to exceed the expectations of our customers."
"We can all look forward to enhancing the value delivered to our customers through continually improving the quality of products and services that will consistently strengthen our business partnerships."
"We take pride in this major accomplishment as we travel together to new heights of 'Better Quality'."
Mettler Toledo chose BVQiNA as their partner in this certification process. BVQi has certified over 70,000 companies around the world and stresses the need for continuous improvement as well as their commitment to adding value throughout the process.
Modified Form of Botox Could Replace Opioids as Treatment for Chronic PainNews
A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to new research.READ MORE
Key Ingredient in Diabetes Drug Modified to Improve Side EffectsNews
Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week. By modifying the key ingredient in current diabetes drugs, the researchers produced a compound that was effective for hyperglycemia in animal trials, yet without the most problematic side effects of current drugs.READ MORE
Tackling Cancer at Ground Zero: Designer Molecule Inhibits Protein TargetNews
A new molecule designed by University of Adelaide researchers shows great promise for future treatment of many cancers. The new molecule successfully targets a protein that plays a major role in the growth of most cancers.READ MORE